New Melanoma Treatment Might Delay Cancer Progression – US News and World Report

“Skin cancers are increasing and melanoma has become a more common part of our lives, but the good news is that treatment is becoming more effective. U.S. News & World Report investigates an exciting discovery by researchers about a two-drug combination that delays treatment resistance in patients with advanced melanoma. “

“This study addresses the problem of resistance to the mitogen-activated protein kinase [MAPK] pathway. The study combined dabrafenib [a selective BRAF inhibitor] and trametinib, [a selective MAPK kinase (MEK) inhibitor]. “

“These drugs can be safely combined, and the survival was significantly improved without untoward side effects,” observes Dr. Michele S. Green, dermatologist at New York’s Lenox Hill Hospital.”